A specific drug, oral mammalian target of rapamycin inhibitor, sirolimus, was also reported to be an effective treatment for extensive lymphatic malformation, but this drug was not used for Chinese ACL patients [19]. The gene discussed is MTOR; the disease is lymphatic malformation.